Avidity Biosciences (RNA) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2026-01-30
• Last 15 days FTD volume: A$0.01 M
• Last 3 months FTD volume: A$14.4 M
• Last 12 months FTD volume: A$46.49 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020

Avidity Biosciences (RNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	A$61.7 M	A$0.13 B	🇺🇸 USA
GSK plc GSK	A$23.88 M	A$0.36 B	🇬🇧 UK
Sarepta Therapeutics SRPT	A$3.87 M	A$21.35 M	🇺🇸 USA
PTC Therapeutics PTCT	A$9.81 M	A$41.89 M	🇺🇸 USA
Fate Therapeutics FATE	A$0.51 M	A$1.36 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	A$0.01 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	A$0.29 M	A$1.04 M	🇺🇸 USA